Leaders in spray and aerosol product testing and contract services; trusted partner in product development from early stage R&D to manufacturing.
Hudson, MA
Joined September 2015
- Tweets532
- Following302
- Followers123
- Likes370
Proveris Scientific retweeted
🚀 @proverisscience helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner. And you can network with them at Formulation & Delivery US 2023!
📖 View networking opportunities: hubs.la/Q01_qG_N0
#FormulationSeries23
Proveris Scientific retweeted
Join FDA and the Center for Research on Complex Generics for the “Considerations for and Alternatives to Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies for Generic Orally Inhaled Drug Products” workshop on April 20-21, 2023. complexgenerics.org/OIDP-CCE…
ALT Considerations for and Alternatives to Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies for Generic Orally Inhaled Drug Products - April 20-21, 2023, 8:30 AM - 5:30 PM, For more information visit: https://complexgenerics.org/events/
Proveris Scientific retweeted
ICS-based inhaled therapy of longer than 6 months associated with reduction in all-cause mortality risk in patients with #COPD in a meta-analysis of 60 RCTs. Read the full original research in the January @journal_CHEST issue: hubs.la/Q01yxkNW0
#MedEd #MedTwitter
Proveris Scientific retweeted
This 🆕 report proposes an in-vitro method to estimate the particle deposition efficiency in the tracheobronchial (TB) and alveolar regions. @UAlberta @proverisscience
Read the full article in Frontiers in Drug Delivery @FrontDrugDDS ⬇
Proveris Scientific retweeted
Today is World Asthma Day! Closing Gaps In Asthma Care has always been a mission for GINA. Download the new 2022 GINA report here: ginasthma.org/gina-reports/ #WorldAsthmaDay #GINA
Proveris Scientific retweeted
OUT NOW!
The #Inhalation Technology Supplement in association with @rddonline is now live!
Featuring @PhillipsMedisiz, @proverisscience, @Nemera, @Presspart, @BroughtonGroup, @PPDCRO, @ELIXPolymers, and more.
Cover image courtesy of @aptar
calameo.com/read/00611338582…
Proveris Scientific retweeted
Did you know that we have a variety of information and learning aids on #inhalers and #nebulizers? This includes instructional videos, webpages, and booklets. See our round-up of inhaler and nebulizer resources at bit.ly/3ugdHkc #COPD #COPDfoundation #MedTwitter
Proveris Scientific retweeted
Teva lanza un spray nasal genérico para la sobredosis de opioides.
#TevaPharma israelnoticias.com/economia/…
Proveris Scientific retweeted
#Press: #Lupin partners with @ttp_plc to develop, manufacture & commercialize #inhalation products using TTP’s soft-mist inhalation technology platform. Read more – bit.ly/TTP-Inhalation
#LupinInNews #Pharmaceuticals #Media #Fenofibrate #USFDA
Proveris Scientific retweeted
Pneumagen Announces Neumifil™ is Efficacious In an Established Model of COVID-19 Infection, read the full press release at bit.ly/3rxOQUY.
#COVID19 #clinicaltrials #drugdevelopment
ALT Nasal inhalation prototype device for delivery of Neumifil
Proveris Scientific retweeted
It’s #COPD Awareness Month and we are amplifying the voices of our amazing community. Join us as we raise awareness of better breathing & exercise, and quality of life & caring for those impacted by COPD. #LaceUpforLungs #COPDAwarenessMonth. Learn more: bit.ly/COPD_nov
Proveris Scientific retweeted
It’s #GlobalHandwashingDay! Handwashing is one of the best ways to protect yourself, your friends, and family from getting sick. Learn how you should wash your hands to stay healthy & when it is most important: go.usa.gov/xEnje.
Proveris Scientific retweeted
It’s been 910 days, but Boston is back.
#RunTo125 #BostonMarathon
Proveris Scientific retweeted
📢It’s #WorldLungDay! Time to acknowledge the need to #ProtectOurLungs and improve air quality.
This year’s themes are:
👉#BeSmokeFree
👉#TakeTheActiveOption
👉#BreatheCleanAir
👉#Vaccinate
@ginasthma @GOLD_COPD @patscommunity @accpchest @ATS_AII @APSRapsr @EuroRespSoc
Proveris Scientific retweeted
.@HerantisPharma announces positive results from our Proof of Concept study with them! The nanoforming process has been successfully applied to rhCDNF, a Parkinson’s disease therapy, opening up real possibilities for intranasal administration.
Read more: bit.ly/2YJFHPD
Proveris Scientific retweeted
DID YOU KNOW? 🧐 Administering Ampion to patients by inhalation allows the drug to directly target #inflammation in the lungs and may attenuate #Covid_19 symptoms. #platformdrug
Proveris Scientific retweeted
The @US_FDA approved our new therapy for the acute treatment of #migraine with and without aura in adults. bit.ly/3kSOVQF #FDAApproval #FDA
Proveris Scientific retweeted
An important characteristic of a #platformdrug is flexibility in how it is delivered to the point of need in the body. Ampion is currently being delivered to patients via:
☑️Local injection
☑️Inhalation
☑️Intravenously (IV)
$SAMPE #biotch